Policy / Pricing Regeneron cuts White House pricing deal, offers new gene therapy for free Pharmaceutical TechnologyThis White House deal will see Regeneron offer all its new medicines at "MFN prices", while providing Otarmeni for free to eligible patients.Policy / PricingGene Therapy PlatformRead full story pharminent April 24, 2026 (Last updated: April 24, 2026) Pharmaceutical Technology This White House deal will see Regeneron offer all its new medicines at “MFN prices”, while providing Otarmeni for free to eligible patients. Policy / PricingGene Therapy PlatformRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Cumberland to sell drug portfolio to Apotex for $100mNext: Cardiometabolic trials: Using expertise to turn complexity into robust results Related Stories Policy / Pricing US generic tariff reprieve on the rocks as Trump proposes 100% rate in 2028 pharminent July 22, 2026 Policy / Pricing UK commits to pharma IP protection in Swiss trade deal pharminent July 16, 2026 Policy / Pricing Germany approves healthcare costs overhaul despite significant pharma opposition pharminent July 13, 2026
